Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Panacea Life Sciences Holdings, Inc. (PLSH : OTC)
 
 • Company Description   
Panacea Life Sciences is involved in production of legal, trace THC, hemp-derived cannabinoid products for consumers and pets. The company produces soft gels, gummies, tinctures, sublingual tablets, cosmetics and other topicals for purchase online and in stores as well as in smart kiosk vending machines. Panacea Life Sciences, formerly known as Exactus Inc., is based in DELRAY BEACH, FL.

Number of Employees: 40

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.04 Daily Weekly Monthly
20 Day Moving Average: 1,093 shares
Shares Outstanding: 20.96 (millions)
Market Capitalization: $0.81 (millions)
Beta: 2.34
52 Week High: $0.14
52 Week Low: $0.03
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.20% -0.66%
12 Week 5.74% -11.06%
Year To Date 54.80% 44.97%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5910 S University Blvd C18-193
-
Greenwood Village,CO 80121
USA
ph: 800-985-0515
fax: -
None http://www.panacealife.com
 
 • General Corporate Information   
Officers
Leslie Buttorff - Chief Executive Officer; Chairman and Chief Financ
Nick Cavarra - President
Nathan Berman - Controller
Lawrence J. Wert - Director
James Baumgartner - Chief Science Officer and Quality Control

Peer Information
Panacea Life Sciences Holdings, Inc. (BJCT)
Panacea Life Sciences Holdings, Inc. (CADMQ)
Panacea Life Sciences Holdings, Inc. (APNO)
Panacea Life Sciences Holdings, Inc. (UPDC)
Panacea Life Sciences Holdings, Inc. (IMTIQ)
Panacea Life Sciences Holdings, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 69810P109
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/29/25
Share - Related Items
Shares Outstanding: 20.96
Most Recent Split Date: 10.00 (0.04:1)
Beta: 2.34
Market Capitalization: $0.81 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/29/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.20
EPS Growth
vs. Year Ago Period: 100.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -43.56%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©